Kennedy Unveils $2.5 Million Lyme Challenges and Deer Tick Pilot as US Cases Reach 476,000
Updated
Updated · The Boston Globe · May 29
Kennedy Unveils $2.5 Million Lyme Challenges and Deer Tick Pilot as US Cases Reach 476,000
3 articles · Updated · The Boston Globe · May 29
New Hampshire hosted Kennedy’s latest Lyme push, centered on a multi-million-dollar pilot to make deer less hospitable to ticks and cut transmission from wildlife to humans.
HHS also plans to award up to $2.5 million through three new LymeX challenges for public-awareness campaigns, frontline tools and AI-based help for Lyme patients and others with invisible illnesses.
The announcement added research funding for Lyme disease and alpha-gal syndrome, while largely steering away from vaccine work after a recent setback in one promising vaccine effort.
CDC estimates about 476,000 Americans are diagnosed and treated for Lyme each year, with cases spreading beyond southern New England and the Mid-Atlantic into the broader Northeast and Upper Midwest.
Kennedy has made Lyme a signature HHS issue since a December roundtable, but his embrace of 'chronic Lyme disease' remains contentious because public health officials instead use post-treatment Lyme disease syndrome.
What are the ecological risks of the new federal plan to eliminate ticks on wildlife?
With current tests failing, when will next-generation Lyme diagnostics finally reach the public?
Pfizer’s Lyme vaccine missed its trial goal. What are its real prospects for approval and public trust?
Lyme Disease Cases Surge to 89,468: HHS Launches Multi-Million Dollar Initiative and LymeX Prize to Transform Diagnosis and Prevention
Overview
Lyme disease cases in the U.S. have risen sharply in recent years, prompting the Department of Health and Human Services to launch a major initiative to address this growing threat. Current diagnostic tools, such as standard and modified two-tiered tests, often fail to detect early infections, especially when symptoms like the erythema migrans rash have been present for less than a week. Because of these limitations, clinicians must rely on their judgment to ensure patients receive timely treatment. Experts stress the urgent need for new diagnostic methods that do not depend on antibody detection, highlighting the importance of innovation in the fight against Lyme disease.